Substantial progress in the treatment of atherosclerotic complications – in particular in secondary prevention – has led to a significant reduction of recurrent cardiovascular events. This has been through the use of pharmacological strategies including lipid-lowering drugs such as statins, beta-blockers, angiotensin-converting ensyme inhibitors and angiotensin receptor blockers, along with the introduction of early percutaneous coronary intervention in acute coronary syndrome with consecutive application of dual antiplatelet therapy.
Atherosclerosis
Atherosclerosis
About
Media
Watch time: 3m 25s
Watch time: 7m 44s
Watch time: 9m 40s
Articles
The Million Hearts Initiative - Targeting Key Drivers of Cardiovascular Mortality from a Medical Specialty Society Perspective
Citation:
US Cardiology 2012;9(1):66-70
- Views:
385
- Downloads:
0
Atherosclerosis Plaque Imaging and Characterization Using Magnetic Resonance Imaging
Citation:
US Cardiology 2005;2(1):129-32
- Views:
75
- Downloads:
0
Support for Combined Administration of Antihypertensive and Lipid-lowering Agents to Reduce Cardiovascular Events—The Emergence of the Multipill
Citation:
US Cardiology 2006;3(2):20–1
- Views:
83
- Downloads:
0
Menopause, Cholesterol and Cardiovascular Disease
Citation:
US Cardiology 2008;5(1):12–4
- Views:
2525
- Downloads:
0